Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone

Basit Öğe Kaydı
dc.contributor.authorErden, İsmail
dc.contributor.authorYalçın, Sübhan
dc.contributor.authorÖzhan, Hakan
dc.date.accessioned2020-04-30T23:32:23Z
dc.date.available2020-04-30T23:32:23Z
dc.date.issued2010
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionWOS: 000284662700009en_US
dc.descriptionPubMed: 20859899en_US
dc.description.abstractA 76 year-old woman with a history of coronary artery bypass grafting and prior myocardial infarction was transferred to the emergency loom with loss of consciousness due to marked bradycardia caused by hyperkalemia The concentration of serum potassium was high, and normal sinus rhythm was restored after correction of the serum potassium level The cause of hyperkalemia was considered to be several doses of spiranolactone, an aldosterone antagonist, in addition to the long-term intake of ramipril, an ACE inhibitor This case is a good example of electrolyte imbalance causing acute life threatening cardiac events Clinicians should be alert to the possibility of hyperkalemia, especially in elderly patients using ACE/ARB in combination with potassium sparing agents and who have mild renal disturbanceen_US
dc.identifier.endpage1046en_US
dc.identifier.issn0022-9032
dc.identifier.issue9en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1043en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12684/4706
dc.identifier.volume68en_US
dc.identifier.wosWOS:000284662700009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherVia Medicaen_US
dc.relation.ispartofKardiologia Polskaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectangiotensin-converting enzyme inhibitorsen_US
dc.subjecthyperkalemiaen_US
dc.subjectaldosteroneen_US
dc.subjectantagonisten_US
dc.subjectsyncopeen_US
dc.titleSyncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactoneen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu